Becker Joel 4

What Happened Joel Becker, CEO of NeuroPace (NPCE), received equity awards on May 15, 2026: 45,880 restricted stock units (RSUs) and 122,190 derivative awards (stock option-type award), both reported at a $0.00 acquisition price. Combined, the grants represent up to 168,070 potential shares; no cash was exchanged. These are compensation awards rather than open-market purchases or sales.

Key Details

• Transaction date: May 15, 2026; Form 4 filed May 19, 2026 (timely within the 2-business-day requirement).
• Awards reported: 45,880 RSUs (line A, $0.00) and 122,190 derivative award (line A, $0.00).
• Shares owned after transaction: Not specified in this filing.
• Footnote F1 (RSUs): Each RSU converts to one share on settlement. 25% vest on May 15, 2027; remaining RSUs vest in twelve equal quarterly installments thereafter.
• Footnote F2 (derivative/option-type award): 25% of option shares vest on May 15, 2027; remaining shares vest in 36 equal consecutive monthly installments thereafter.
• No indication of sale, tax withholding, 10b5-1 plan, or cashless exercise in this filing.

Context These grants are standard long-term compensation tied to future vesting — not immediate purchases or sales — so they reflect expected retention incentives rather than an immediate statement about market sentiment. The derivative award vests over time; the filing does not show any immediate exercise or disposition.